John Hopkins Kimmel Cancer Center

401 North Broadway
Baltimore, Maryland 21287

We've found

2 trials

at this facility

A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Baltimore, MD

ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancer

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Baltimore, MD

Use our guide to learn which trials are right for you!